TWM616223U - Biological infection response system - Google Patents
Biological infection response system Download PDFInfo
- Publication number
- TWM616223U TWM616223U TW110200691U TW110200691U TWM616223U TW M616223 U TWM616223 U TW M616223U TW 110200691 U TW110200691 U TW 110200691U TW 110200691 U TW110200691 U TW 110200691U TW M616223 U TWM616223 U TW M616223U
- Authority
- TW
- Taiwan
- Prior art keywords
- state
- biological
- screened
- person
- identity
- Prior art date
Links
Images
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
本創作係關於一種生物感染檢測與管制的技術領域，尤指一種生物感染應變系統。 This creation is about a technical field of biological infection detection and control, especially a biological infection response system.
在環境中充斥著許多對人體有害的病毒，當人類對於病毒沒有抵抗能力時，將會危及到人類的生命。近年來，嚴重急性呼吸道症候群冠狀病毒(SARS-CoV)與嚴重特殊傳染性肺炎(COVID-19)所引發的大流行疫情，造成許多人類死亡。 The environment is full of viruses that are harmful to the human body. When human beings have no ability to resist the virus, it will endanger human life. In recent years, the pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV) and severe special infectious pneumonia (COVID-19) has caused many human deaths.
人類都需要透過呼吸才能夠生存，因而在未有任何防護措施下，病毒往往很容易透過空氣進入到人類的呼吸道進而感染人類；但是，人類可以透過例如疫苗、自我防護等方式，降低感染的風險。 Humans need to breathe to survive. Therefore, without any protective measures, viruses can easily enter the human respiratory tract through the air and infect humans. However, humans can reduce the risk of infection through methods such as vaccines and self-protection. .
然而，有時候病毒存在潛伏期讓感染者不知道自身已經感染了病毒或是感染者自身雖不受到病毒的影響但是卻能夠散播病毒，若這樣子的感染者無法及時地被察覺或是管制，將會對其他健康的人類造成重要的影響，進而造成大量的感染。 However, sometimes the virus has an incubation period so that the infected person does not know that they have been infected with the virus or the infected person is not affected by the virus but can spread the virus. If such an infected person cannot be detected or controlled in time, it will It will have an important impact on other healthy humans and cause a large number of infections.
有鑑於此，本創作提供一種生物感染檢測方法、生物感染檢測與人員管制方法與生物感染應變系統，用以解決前述的問題。 In view of this, this creation provides a biological infection detection method, a biological infection detection and personnel control method, and a biological infection response system to solve the aforementioned problems.
本創作之第一目的提供一種生物感染檢測方法，係用於檢測被篩檢者是否受到感染，並且根據檢測結果判斷生物樣本屬於第一狀態、第二狀態或無法判定狀態。 The first purpose of this creation is to provide a biological infection detection method, which is used to detect whether the screened person is infected, and to determine whether the biological sample belongs to the first state, the second state, or the undeterminable state based on the detection result.
本創作之第二目的係根據前述的生物感染檢測方法，藉由綁定識別碼與被篩檢者的身份，以確認篩檢結果的唯一性。 The second purpose of this creation is to confirm the uniqueness of the screening results by binding the identification code and the identity of the screened person according to the aforementioned biological infection detection method.
本創作之第三目的係根據前述的生物感染檢測方法，執行人工智能演算法或圖像識別演算法演算檢測結果的影像，以判定被篩檢者的生物樣本屬於第一狀態、第二狀態或無法判定狀態。 The third purpose of this creation is to execute the artificial intelligence algorithm or image recognition algorithm to calculate the image of the detection result based on the aforementioned biological infection detection method to determine whether the biological sample of the screened person belongs to the first state, the second state or Unable to determine the status.
本創作之第四目的係根據前述的生物感染檢測方法，藉由提供電子裝置掃瞄識別碼和被篩檢者的身份(例如證件、個人資料、生物特徵及/或行為特徵等)，使得篩檢套件綁定電子裝置以形成該關聯識別碼。 The fourth purpose of this creation is based on the aforementioned biological infection detection method, by providing an electronic device to scan the identification code and the identity of the screened person (such as credentials, personal data, biometrics and/or behavioral characteristics, etc.) to enable screening The inspection kit binds the electronic device to form the associated identification code.
本創作之第五目的係根據前述的生物感染檢測方法，紀錄將被篩檢者之生物樣本採檢與設置檢測區的執行者，例如執行者為被篩檢者自身或非被篩檢者，用以判斷生物樣本是否為可信任的樣本可供檢測。 The fifth purpose of this creation is based on the aforementioned biological infection detection method to record the executors who collect the biological samples of the screened person and set up the detection area, for example, the executor is the screened person or the non-screened person, It is used to determine whether the biological sample is a trustworthy sample for testing.
本創作之第六目的係根據前述的生物感染檢測方法，電子裝置提供影像擷取單元，以擷取該執行者的操作影像，且在影像擷取單元擷取操作影像的過程中，載入引導影像以引導執行者取得生物樣本，並且比對引導影像與操作影像之間的影像差異，以判斷採樣的過程是否正確。 The sixth purpose of this creation is based on the aforementioned biological infection detection method. The electronic device provides an image capture unit to capture the operation image of the executor, and loads the guide during the process of capturing the operation image by the image capture unit The image guides the performer to obtain a biological sample, and compares the image difference between the guided image and the operating image to determine whether the sampling process is correct.
本創作之第七目的係根據前述的生物感染檢測方法，若執行者為非被篩檢者，則執行者需提供第三方憑證以設置被篩檢者之生物樣本於檢測區，而執行者未能提供第三方憑證，則等待執行者提供第三方憑證、改由被篩檢者自身進行檢測或取消檢測。 The seventh purpose of this creation is based on the aforementioned biological infection detection method. If the executor is a non-screened person, the executor needs to provide a third-party certificate to set the biological sample of the screened person in the detection area, and the executor does not If a third-party certificate can be provided, it will wait for the executor to provide the third-party certificate, and the screened person will conduct the test or cancel the test.
本創作之第八目的係根據前述的生物感染檢測方法，在檢測結果被判定為第一狀態時，執行通報應用程序；在檢測結果被判定為第一狀態時，執行回報應用程序；以及，在檢測結被判定為無法判定狀態時，執行重驗應用程序。 The eighth purpose of this creation is to execute the notification application when the detection result is judged to be the first state according to the aforementioned biological infection detection method; when the detection result is judged to be the first state, execute the report application; and, When the detection result is judged to be in an undecidable state, the recheck application is executed.
本創作之第九目的係根據前述的生物感染檢測方法，要求被篩檢者提供輔助判斷資料，例如輔助判斷資料為旅遊歷史、病史、接觸歷史或健康證明，以維持非異常訊息，或是在潛伏時間內或之後重新執行生物感染檢測方法。 The ninth purpose of this creation is to require the screened person to provide auxiliary judgment data based on the aforementioned biological infection detection method, such as travel history, medical history, contact history, or health certificate to maintain non-abnormal information, or Re-execute the biological infection detection method within or after the incubation time.
本創作之第十目的係根據前述的生物感染檢測方法，回報應用程序能夠發出通行憑證，且通行憑證選擇性附加有效時間，以決定憑證失效或有效的，當逾越有效時間，通行憑證失效。 The tenth purpose of this creation is based on the aforementioned biological infection detection method, the report application can issue a pass certificate, and the pass certificate optionally adds a valid time to determine whether the certificate is invalid or valid. When the valid time expires, the pass certificate becomes invalid.
本創作之第十一目的提供一種生物感染檢測與人員管制方法，係用於檢測被篩檢者是否受到感染和針對被篩檢者選擇性實施行動管制。 The eleventh purpose of this creation is to provide a biological infection detection and personnel control method, which is used to detect whether the screened person is infected and selectively implement action control for the screened person.
本創作之第十二目的係根據上述生物感染檢測與人員管制方法，根據第一狀態、第二狀態或無法判定狀態選擇性對被篩檢者實施行動管制。 The twelfth purpose of this creation is to selectively implement action control on the screened person based on the above-mentioned biological infection detection and personnel control methods, according to the first state, the second state or the undecidable state.
本創作之第十三目的係根據上述生物感染檢測與人員管制方法，在虛擬地圖劃定被被篩檢者的活動範圍和藉由比對被篩檢者在實際地理位置的座標，以判斷被篩檢者位於活動範圍。 The thirteenth objective of this creation is to delineate the scope of activities of the screened person on a virtual map based on the above-mentioned biological infection detection and personnel control methods and determine the screened person by comparing the screened person’s coordinates in the actual geographic location. The examiner is in the range of activity.
本創作之第十四目的係根據上述生物感染檢測與人員管制方法，在虛擬地圖標記屬於第一狀態或無法判定狀態之被篩檢者的該座標，以選擇性推播與顯示於任何人或指定人。 The fourteenth purpose of this creation is based on the above biological infection detection and personnel control methods, marking the coordinates of the screened person in the first state or the undeterminable state on the virtual map, so as to selectively push and display it to any person or Designated person.
本創作之第十五目的提供一種生物感染應變系統，係提供具有識別碼與檢測區的篩檢套件檢測被篩檢者是否受到感染與針對被篩檢者選擇性實施行動管制。 The fifteenth purpose of this creation is to provide a biological infection response system, which provides a screening kit with an identification code and a detection area to detect whether the screened person is infected and selectively implement action control for the screened person.
為了達到上述目的與其他目的，本創作提供一種生物感染檢測方法，係包含步驟(a)，係提供具有一識別碼與一檢測區的一篩檢套件；步驟(b)，係綁定識別碼與一被篩檢者的身份，使得篩檢套件關聯於身份，其中經綁定身份的識別碼界定為一關聯識別碼；步驟(c)，係設置被篩檢者之一生物樣本於檢測區，其中生物樣本係直接採檢被篩檢者的一組織或一體液所獲得，或者生物樣本係在採檢被篩檢者的組織或體液後進一步混合一試劑所獲得；步驟(d)，係檢測區顯示經檢測生物樣本的一檢測結果；步驟(e)，係比對關聯識別碼，以確定是被篩檢者的檢測結果；以及步驟(f)，係根據檢測結果，以判斷生物樣本屬於一第一狀態、一第二狀態或一無法判定狀態。 In order to achieve the above and other objectives, this creation provides a biological infection detection method, which includes step (a), providing a screening kit with an identification code and a detection area; step (b), binding the identification code With the identity of a screened person, the screening kit is associated with the identity, where the identification code of the bound identity is defined as an associated identification code; step (c) is to set a biological sample of the screened person in the detection area , Wherein the biological sample is obtained by directly sampling a tissue or body fluid of the screened person, or the biological sample is obtained by further mixing a reagent after sampling the tissue or body fluid of the screened person; step (d) is The detection area displays a test result of the tested biological sample; step (e) is to compare the associated identification code to confirm that it is the test result of the screened person; and step (f) is to judge the biological sample based on the test result Belongs to a first state, a second state, or an undecidable state.
為了達到上述目的與其他目的，本創作提供一種生物感染檢測與人員管制方法，更包含步驟(a1)，係提供具有一識別碼與一檢測區的一篩檢套件；步驟(b1)，係綁定識別碼與一被篩檢者的身份，使得篩檢套件關聯於身份，其中經綁定身份的識別碼界定為一關聯識別碼；步驟(c1)，係設置被篩檢者之一生物樣本於檢測區，其中生物樣本係直接採檢被篩檢者的一組織或一體液所獲得，或者生物樣本係在採檢被篩檢者的組織或體液後進一步混合一試劑所獲得；步驟(d1)，係檢測區顯示經檢測生物樣本的一檢測結果；步驟(e1)，係比對關聯識別 碼，以確定是被篩檢者的檢測結果；步驟(f1)，係根據檢測結果，以判斷生物樣本屬於一第一狀態、一第二狀態或一無法判定狀態；以及步驟(g1)，係根據第一狀態、第二狀態或無法判定狀態選擇性對被篩檢者實施一行動管制。 In order to achieve the above and other purposes, this creation provides a biological infection detection and personnel control method, and further includes step (a1), providing a screening kit with an identification code and a detection area; step (b1), binding Determine the identification code and the identity of a screened person, so that the screening kit is associated with the identity, where the identification code bound to the identity is defined as an associated identification code; step (c1) is to set a biological sample of the screened person In the detection area, the biological sample is obtained by directly sampling a tissue or body fluid of the screened person, or the biological sample is obtained by further mixing a reagent after sampling the tissue or body fluid of the screened person; step (d1 ), the detection area displays a detection result of the tested biological sample; step (e1), is the correlation identification Code to confirm that it is the test result of the screened person; step (f1), based on the test result, determine whether the biological sample belongs to a first state, a second state, or an undeterminable state; and step (g1) is According to the first state, the second state or the undecidable state, an action control is selectively implemented on the screened person.
為了達到上述目的與其他目的，本創作提供一種生物感染應變系統，係提供具有一識別碼與一檢測區的一篩檢套件檢測一被篩檢者是否受到感染與針對被篩檢者選擇性實施一行動管制，其中被篩檢者之生物樣本設置於檢測區，且生物樣本係直接採檢被篩檢者的一組織或一體液所獲得或生物樣本係在採檢被篩檢者的組織或體液後進一步混合一試劑所獲得。生物感染應變系統包含一輸入元件與一處理元件。輸入元件係設置於篩檢套件以取得檢測區顯示檢測結果，其中檢測結果為一影像型態與一文字型態之至少一者。處理元件係連接輸入元件，且處理元件執行一生物感染檢測程序綁定識別碼與被篩檢者的身份以關聯篩檢套件與身份，以及執行生物感染檢測程序以判斷生物樣本屬於一第一狀態、一第二狀態或一無法判定狀態。 In order to achieve the above and other purposes, this creation provides a biological infection response system, which provides a screening kit with an identification code and a detection area to detect whether a screened person is infected and selectively implement it for the screened person A movement control, in which the biological sample of the screened person is set in the detection area, and the biological sample is directly collected from a tissue or body fluid of the screened person or the biological sample is collected from the screened person’s tissue or It is obtained by further mixing a reagent after the body fluid. The biological infection strain system includes an input element and a processing element. The input element is arranged in the screening kit to obtain the detection area and display the detection result, wherein the detection result is at least one of an image type and a text type. The processing element is connected to the input element, and the processing element executes a biological infection detection program, binds the identification code and the identity of the screened person to associate the screening kit with the identity, and executes the biological infection detection program to determine that the biological sample belongs to a first state , A second state or an undecidable state.
相較於習知技術，本創作提供的生物感染檢測方法、生物感染檢測與人員管制方法與生物感染應變系統，可以由合格的採檢生物樣本的人員對於被篩檢者進行採檢或是由被篩檢者自行進行採檢，而透過採檢之後的結果，可以根據採檢結果判斷被篩檢者是否感染，且可以同時確定篩檢結果是唯一屬於被篩檢者，其可以有效地確定採檢結果來自於被篩檢者。另外，本創作還可以透過影像識別的技術，對篩檢結果的影像進行分析，以判斷篩檢結果，例如呈現陽性、陰性或不明確等。再者，本創作可以對具有正常篩檢結果的被篩檢者發出通行憑證或根據異常的篩檢結果限制被篩檢者的活動範圍，以有效地對被篩檢者 進行管制，避免疫情的擴散。此外，本創作提供生物感染應變系統以達到執行生物感染檢測與人員管制方法的目的。 Compared with the conventional technology, the biological infection detection method, biological infection detection and personnel control method and biological infection response system provided by this creation can be tested by qualified personnel who collect biological samples or be screened by The screened person carries out the test on his own, and through the results of the test, it can be judged whether the screened person is infected according to the test result, and it can be determined at the same time that the screening result belongs to the screened person, which can effectively determine The results of the screening come from the person being screened. In addition, this creation can also use image recognition technology to analyze the images of the screening results to determine the screening results, such as positive, negative, or unclear. Furthermore, this creation can issue a pass to the screened person with normal screening results or restrict the screened person’s range of activities based on abnormal screening results, so as to effectively treat the screened person. Carry out control to avoid the spread of the epidemic. In addition, this creation provides a biological infection response system to achieve the purpose of implementing biological infection detection and personnel control methods.
S11-S16:步驟 S11-S16: steps
S31-S32:步驟 S31-S32: steps
S51:步驟 S51: Step
1:電子裝置 1: Electronic device
2:篩檢套件 2: Screening kit
22:識別碼 22: identification code
24:檢測區 24: detection area
4:被篩檢者 4: Screened person
42:生物樣本 42: Biological sample
10、10’:生物感染應變系統 10, 10’: Biological infection response system
12:輸入元件 12: Input components
14:處理元件 14: processing components
DR:檢測結果 DR: test result
BIDAPP:生物感染檢測程序 BIDAPP: Biological infection detection program
BIPCAPP:生物感染人員管制應用程序 BIPCAPP: Biological infection personnel control application
ID:身份 ID: Identity
FS:第一狀態 FS: first state
SS:第二狀態 SS: second state
LOJS:無法判定狀態 LOJS: Unable to determine status
GS:引導畫面 GS: Boot screen
OS:操作畫面 OS: Operation screen
圖1係本創作第一實施例之生物感染檢測方法之流程圖。 Figure 1 is a flowchart of the biological infection detection method of the first embodiment of the present creation.
圖2係說明本創作圖1之篩檢套件的結構示意圖。 Figure 2 is a schematic diagram illustrating the structure of the screening kit of Figure 1 of the present creation.
圖3係本創作第二實施例之生物感染檢測方法之流程圖。 Fig. 3 is a flowchart of the biological infection detection method according to the second embodiment of the present creation.
圖4係說明本創作圖3之電子裝置的引導畫面示意圖。 FIG. 4 is a schematic diagram illustrating the guide screen of the electronic device in FIG. 3 of the present creation.
圖5係本創作第三實施例之生物感染檢測與人員管制方法之流程圖。 Fig. 5 is a flowchart of the biological infection detection and personnel control method of the third embodiment of the present creation.
圖6係本創作第四實施例之生物感染應變系統之方塊圖。 Fig. 6 is a block diagram of the biological infection response system of the fourth embodiment of the present creation.
圖7係本創作第五實施例之生物感染應變系統之方塊圖。 Fig. 7 is a block diagram of the biological infection response system of the fifth embodiment of the present creation.
由於各種態樣與實施例僅為例示性且非限制性，故在閱讀本說明書後，具有通常知識者可知在不偏離本創作之範疇下，亦可能有其他態樣與實施例。根據下述之詳細說明與申請專利範圍，將可使該等實施例之特徵及優點更加彰顯。 Since the various aspects and embodiments are only illustrative and non-limiting, after reading this specification, those with ordinary knowledge will know that other aspects and embodiments are possible without departing from the scope of this creation. According to the following detailed description and the scope of patent application, the features and advantages of these embodiments will be more prominent.
於本文中，係使用「一」或「一個」來描述本文所述的元件和組件。此舉只是為了方便說明，並且對本創作之範疇提供一般性的意義。因此，除非很明顯地另指他意，否則此種描述應理解為包括一個或至少一個，且單數也同時包括複數。 In this article, "a" or "an" is used to describe the elements and components described in this article. This is just for the convenience of explanation and to provide a general meaning to the scope of this creation. Therefore, unless it is clearly stated otherwise, this description should be understood to include one or at least one, and the singular number also includes the plural number.
此外，於本文中，用語「包括」、「具有」或其他任何類似用語意欲涵蓋非排他性之包括物。舉例而言，含有複數要件的元件或結構不僅限於本文所列出之此等要件而已，而是可以包括未明確列出但卻是該元件或結構通常固有之其他要件。 In addition, in this article, the terms "include", "have" or any other similar terms are intended to cover non-exclusive inclusions. For example, an element or structure containing a plurality of elements is not limited to the elements listed herein, but may include other elements that are not explicitly listed but are usually inherent to the element or structure.
請參考圖1，係本創作第一實施例之生物感染檢測方法之流程圖。在圖1中，生物感染檢測方法係起始於步驟S11，係提供具有一識別碼與一檢測區的一篩檢套件，一併可以參照圖2的示意圖，圖2係說明本創作圖1之篩檢套件的結構示意圖，例如識別碼可為QR code、條碼、圖案碼等可視碼或是非可視的RDIF碼等。在圖2中，顯示篩檢套件2、識別碼22與一檢測區24。
Please refer to Fig. 1, which is a flowchart of the biological infection detection method according to the first embodiment of this creation. In Figure 1, the biological infection detection method starts at step S11, which provides a screening kit with an identification code and a detection area. You can also refer to the schematic diagram of Figure 2. Figure 2 illustrates the creation of Figure 1 The structure diagram of the screening kit, for example, the identification code can be a visual code such as a QR code, a barcode, a pattern code, or a non-visual RDIF code, etc. In FIG. 2, the
步驟S12，係綁定識別碼與一被篩檢者的身份，使得篩檢套件關聯於身份。其中，經綁定身份的識別碼界定為一關聯識別碼。值得注意的是，識別碼經綁定形成關聯識別碼之後，識別碼禁止再次被綁定。又，綁定的方法例舉如下： Step S12 is to bind the identification code to the identity of a screened person, so that the screening kit is associated with the identity. Among them, the identification code of the bound identity is defined as an associated identification code. It is worth noting that after the identification code is bound to form an associated identification code, the identification code is prohibited from being bound again. Also, examples of binding methods are as follows:
方法一、提供電子裝置掃瞄識別碼，使得篩檢套件綁定電子裝置以形成關聯識別碼。其中，電子裝置預先地綁定被篩檢者的身份，換言之，電子裝置可以是由被篩檢者所擁有，且電子裝置已經預先的綁定被篩檢者，例如電子裝置可以是智慧型手機、平板等，藉由使用者身分模組(Subscriber Identity Module，SIM)、媒體存取控制位址(Media Access Control Address，MAC address)、國際行動裝置辨識碼(International Mobile Equipment Identity，IMEI)綁定被篩檢者的身份，使得具有唯一性的使用者身分模組、媒體存取控制位址或國際行動裝置辨識碼用來綁定被篩檢者的身份。 Method 1: Provide the electronic device scanning identification code, so that the screening kit is bound to the electronic device to form an associated identification code. Among them, the electronic device is pre-bound with the identity of the screened person. In other words, the electronic device can be owned by the screened person, and the electronic device has been pre-bound to the screened person, for example, the electronic device can be a smart phone. , Tablet, etc., bound by Subscriber Identity Module (SIM), Media Access Control Address (MAC address), International Mobile Equipment Identity (IMEI) The identity of the screened person enables a unique user ID module, media access control address or international mobile device identification code to bind the screened person's identity.
方法二、提供電子裝置掃瞄識別碼與被篩檢者的證件，例如證件可為身分證、護照等可以證明或記載有被篩檢者的文件，藉由掃瞄識別碼與證件進而使得篩檢套件可以藉由綁定證件以形成該關聯識別碼，其中該證件預先地綁定該被篩檢者的該身份。 Method 2: Provide an electronic device to scan the identification code and the identification of the screened person. For example, the identification can be an ID card, passport, etc. that can prove or record the screened person’s documents. Scan the identification code and the identification to make the screening The inspection kit can form the associated identification code by binding a certificate, wherein the certificate is pre-bound with the identity of the screened person.
方法三、提供電子裝置掃瞄識別碼與取得被篩檢者的個人資料、生物特徵與行為特徵之至少一者的身份，以使得篩檢套件綁定身份、生物特徵或行為特徵而形成關聯識別碼。其中，個人資料可為姓名、年齡、地址、病史、旅遊史等；生物特徵可為指紋、掌紋、掌型、虹膜、面容、聲紋、去氧核糖核酸(deoxyribonucleic acid，DNA)；以及，行為特徵則有走路姿勢、心跳、簽名、手勢等。 Method 3: Provide the electronic device to scan the identification code and obtain the identity of at least one of the personal data, biometrics and behavioral characteristics of the screened person, so that the screening kit binds the identity, biometrics or behavioral characteristics to form an associated identification code. Among them, personal information can be name, age, address, medical history, travel history, etc.; biological characteristics can be fingerprints, palm prints, palm shape, iris, facial features, voice prints, deoxyribonucleic acid (DNA); and, behavior Features include walking posture, heartbeat, signature, and gestures.
上述方法中，可以在步驟S12之前，執行步驟S31，可一併參考圖3，係本創作第二實施例之生物感染檢測方法之流程圖。在步驟S31中，係提供註冊程序取得被篩檢者的身分，以綁定電子裝置與身分。舉例而言，註冊程序提供網頁的介面，能夠提示被篩檢者提供相關於身份的資料與特徵，例如姓名、年齡、地址、病史、旅遊史、指紋、掌紋、掌型、虹膜、面容、聲紋、去氧核糖核酸、走路姿勢、心跳、簽名、手勢等，以及被篩檢者所使用的之電子裝置之使用者身分模組、媒體存取控制位址、國際行動裝置辨識碼、相關於該身份的與該被篩檢者的生物特徵之至少一者。 In the above method, step S31 may be performed before step S12, and reference may be made to FIG. 3, which is a flowchart of the biological infection detection method according to the second embodiment of the present invention. In step S31, a registration program is provided to obtain the identity of the screened person to bind the electronic device and the identity. For example, the registration process provides a web interface that can prompt the screened person to provide identity-related information and characteristics, such as name, age, address, medical history, travel history, fingerprints, palm prints, palm shape, iris, face, voice Patterns, DNA, walking posture, heartbeat, signature, gestures, etc., as well as the user identity module of the electronic device used by the screened person, media access control address, international mobile device identification code, and related At least one of the identity and the biological characteristics of the screened person.
又，於另一步驟中，可以在執行步驟S12之前，先執行以下的步驟，以確定是否要執行步驟S12。 Moreover, in another step, the following steps may be performed before step S12 is performed to determine whether to perform step S12.
提供調查表格，以供該被篩檢者填寫。其中，調查表格為個人資料、旅遊歷史、接觸歷史與疾病歷史之至少一者和判斷調查表格的完成度，以決定執行步驟S12與後續步驟S13至步驟S16。 Provide a survey form for the screened person to fill out. Wherein, the survey form is at least one of personal data, travel history, contact history, and disease history, and the degree of completion of the survey form is judged to determine the execution of step S12 and subsequent steps S13 to S16.
步驟S13，係設置被篩檢者之一生物樣本於檢測區。其中，生物樣本係直接採檢被篩檢者的一組織或一體液所獲得，或者生物樣本係在採檢被篩檢者的組織或體液後進一步混合一試劑所獲得。 Step S13 is to set a biological sample of one of the screened persons in the detection area. Among them, the biological sample is obtained by directly collecting a tissue or body fluid of the screened person, or the biological sample is obtained by further mixing a reagent after collecting the tissue or body fluid of the screened person.
又，在執行步驟S13之前，可以執行步驟S32，係可以先記錄執行採樣被篩檢者之生物樣本並設置檢測區的執行者，例如執行者為被篩檢者自身或非被篩檢者，以非被篩檢者而言，例如可為醫生、護理師、經過訓練合格的人員。紀錄的目的，是可以進一步判斷被篩檢者的生物樣本在採集生物樣本的過程中是否正確，正確的取樣才能夠有正確的檢測結果；反之，則反。又，紀錄的方式，除了文字或是圖片的形式之外，還可以提供影像擷取單元取得執行者的影像或是操作過程的影像，例如攝影機或是電子裝置的攝影鏡頭。 Furthermore, before step S13 is performed, step S32 can be performed, which is to record the executor who performed the sampling of the biological sample of the screened person and set the detection area, for example, the executor is the screened person or the non-screened person, For non-screened persons, for example, they can be doctors, nurses, and trained personnel. The purpose of the record is to further determine whether the biological sample of the screened person is correct in the process of collecting the biological sample, and the correct sampling can have the correct detection result; otherwise, the reverse is true. Moreover, in addition to the form of text or pictures, the recording method can also provide an image capturing unit to obtain images of the performer or an image of the operation process, such as a camera or a camera lens of an electronic device.
又，於另一實施例中，在步驟S32中，可以提供一個引導教示的文字、圖片或影像引導執行者，特別是執行者是被篩檢者自己本身。舉例而言，被篩檢者可以藉由電子裝置提供影像擷取單元以擷取執行者採取生物樣本的操作過程的操作影像，且同時在電子裝置顯示引導影像以引導執行者正確的採取生物樣本。因此，引導影像是相關於執行者採取生物樣本的方法步驟。可一併參考圖4，係說明本創作圖3之電子裝置的引導畫面示意圖。在圖4中，顯示電子裝置1、引導畫面GS與操作畫面OS。又，於本實施例中，比對引導影像與操作影像之間的影像差異，進而決定是否需要重行執行步驟S11與S12。 Furthermore, in another embodiment, in step S32, a text, picture or image for guiding the teaching may be provided to guide the executor, especially the executor is the screened person himself. For example, the screened person can use the electronic device to provide an image capturing unit to capture the operation image of the operation process of the performer taking the biological sample, and at the same time display the guiding image on the electronic device to guide the performer to correctly take the biological sample . Therefore, guided imagery is related to the method steps used by the performer to take biological samples. Please also refer to FIG. 4, which is a schematic diagram illustrating the guide screen of the electronic device in FIG. 3 of the present invention. In FIG. 4, the electronic device 1, the guide screen GS, and the operation screen OS are displayed. Moreover, in this embodiment, the image difference between the guide image and the operation image is compared to determine whether it is necessary to perform steps S11 and S12 again.
值得注意的是，前述所提及經過訓練合格的人員，在步驟S13可以進一步要求執行者提供第三方憑證且經比對第三方憑證為有效憑證之後，才可以執行步驟S31；反之，若執行者未能提供第三方憑證或第三方憑證無效時，則等待執行者提供第三方憑證或取消檢測。 It is worth noting that the above-mentioned trained and qualified personnel may further require the executor to provide a third-party certificate in step S13 and the third-party certificate is compared to be a valid certificate before performing step S31; on the contrary, if the executor If the third-party certificate cannot be provided or the third-party certificate is invalid, it will wait for the executor to provide the third-party certificate or cancel the test.
關於第三方憑證的發出，可以透過第三方機構的專業訓練與專業認證，進而發出可以從事採取生物樣本的第三方憑證。第三方憑證可以提高採樣的精確性與判讀的正確性。 Regarding the issuance of third-party certificates, the professional training and professional certification of third-party institutions can be used to issue third-party certificates that can engage in the collection of biological samples. Third-party certificates can improve the accuracy of sampling and the correctness of interpretation.
回到圖1，步驟S14，係檢測區顯示經檢測生物樣本的一檢測結果。在本步驟中，還可以更包含一等待時間，以提示與計數之至少一者的方式，讓生物樣本在等待時間或在等待時間之內於檢測區呈現檢測結果，換言之，生物樣本需要有足夠的時間跟篩檢套件進行作用，才能夠顯示出正確的檢測結果。等待時間的設定依照篩檢套件的不同而設定，例如等待時間為數十秒、數分鐘或數十分鐘。藉由提示或是計數的方式，可以讓執行者可以知道還需要多長的時間或是自行計算需要多長的時間等待檢測區顯示檢測結果。 Returning to Figure 1, step S14, the detection area displays a detection result of the detected biological sample. In this step, it may further include a waiting time, which allows the biological sample to present the detection result in the detection area during the waiting time or within the waiting time by means of at least one of prompting and counting. In other words, the biological sample needs to have enough The time required to interact with the screening kit can show the correct test results. The waiting time is set according to the different screening kits. For example, the waiting time is tens of seconds, minutes, or tens of minutes. By means of prompts or counting, the executor can know how long it takes or calculate how long it takes to wait for the detection area to display the detection result.
步驟S15，係比對關聯識別碼，以確定是被篩檢者的檢測結果。於本步驟中，藉由確定關聯識別碼以能夠確定檢測結果是屬於被篩檢者。 In step S15, the correlation identification code is compared to determine the detection result of the screened person. In this step, by determining the associated identification code, it can be determined that the detection result belongs to the screened person.
步驟S16，係根據檢測結果，以判斷生物樣本屬於一第一狀態、一第二狀態或一無法判定狀態。於本步驟中，可以進一步描述如下： Step S16 is to determine whether the biological sample belongs to a first state, a second state, or an undeterminable state according to the detection result. In this step, it can be further described as follows:
(1)在檢測結果被判定為第一狀態時，執行通報應用程序。通報應用程序是向預設的指定對象進行通報與警示，以及選擇性向被篩檢者發出檢出異常訊息。其中，第一狀態可為陽性、偽陽性等狀態。 (1) When the detection result is determined to be the first state, the notification application is executed. The notification application is to notify and warn the preset designated objects, and selectively send out abnormal detection messages to the screened persons. Among them, the first state can be positive, false positive and other states.
(2)在檢測結果被判定為第二狀態時，執行回報應用程序。回報應用程序是向被篩檢者發出檢出非異常訊息。其中，第二狀態可為陰性、偽陰性等狀態。 (2) When the detection result is determined to be the second state, the report application is executed. The report application is to send a non-abnormal detection message to the screened person. Among them, the second state can be negative, false negative and other states.
值得注意的是，於此所述的第二狀態，有可能因為潛伏時間(或稱潛伏期)未被檢出或是採樣過程有誤而出現例如陰性或偽陰性的情況，故在(2)中，回報應用程序更進一步要求被篩檢者提供輔助判斷資料，例如旅遊歷史、病史、接觸歷史、活動軌跡、健康證明等，以維持非異常訊息。於另一實施例中，若已經知道潛伏時間，可以在潛伏時間之內或之後，要求被篩檢者重新執行步驟S11至S16。 It is worth noting that the second state described here may be negative or false negative because the incubation time (or the incubation period) is not detected or the sampling process is incorrect. Therefore, in (2) , The report application further requires the screened person to provide auxiliary judgment data, such as travel history, medical history, contact history, activity trajectory, health certificate, etc., to maintain non-abnormal information. In another embodiment, if the incubation time is already known, the screened person may be required to perform steps S11 to S16 again within or after the incubation time.
又，回報應用程序還可以發出通行憑證，例如通行憑證可為QR code、條碼、圖案碼等。在另一實施例中，前述通行憑證可以另外附加有效時間，當逾越有效時間，則通行憑證失效。實際的方式，可以透過伺服器管理通行憑證，通行憑證可以包含發出時間、截止時間、延長次數、延長時間等設定，藉由前述該等時間演算，例如當前時間與截止時間的比對，可以決定通行憑證的有效性，以此類推。 In addition, the reporting application can also issue a pass voucher, for example, the pass voucher can be a QR code, a barcode, a pattern code, etc. In another embodiment, the aforementioned pass voucher may additionally have a valid time attached. When the valid time is exceeded, the pass voucher becomes invalid. In a practical way, the pass certificate can be managed through the server. The pass certificate can include the issuance time, expiration time, extension times, extension time and other settings, which can be determined by the aforementioned calculation of these times, such as the comparison between the current time and the expiration time The validity of the pass, and so on.
又，回報應用程序還可以不定時地要求受被篩檢者提供自我健康管理內容或執行步驟S11至S16，以決定延長有效時間，例如自我健康管理內容為呼吸、體溫、嗅覺、味覺、疲倦、氣喘等。 In addition, the report application can also ask the screened person to provide self-health management content from time to time or perform steps S11 to S16 to determine the extension of the effective time. For example, the self-health management content includes breathing, body temperature, smell, taste, fatigue, Asthma and so on.
(3)在檢測結被判定為無法判定狀態時，執行重驗應用程序。重驗應用程序是向被篩檢者發出重新執行步驟S11至S16的重新檢測訊息。其中，無法判定狀態可為無法正確顯示陽性或陰性狀態，以及偽陽性與偽陰性等狀態。 (3) When the detection result is judged to be in an undecidable state, the recheck application is executed. The re-inspection application program is to send a re-inspection message for re-executing steps S11 to S16 to the screened person. Among them, the undeterminable state may be a state that cannot be correctly displayed positive or negative, and states such as false positive and false negative.
又，在步驟S16中，更包含執行人工智能演算法或圖像識別演算法演算檢測結果的影像，以判定被篩檢者的生物樣本屬於第一狀態、第二狀態或無法判定狀態。 In addition, in step S16, it further includes performing an artificial intelligence algorithm or an image recognition algorithm to calculate the image of the detection result to determine that the biological sample of the screened person belongs to the first state, the second state, or the undeterminable state.
前述中，通報應用程序、回報應用程序與重驗應用程序等程序可為程式碼所構成以驅使電子裝置之軟體或硬體而達成該等應用程序所欲達成的目的。 In the foregoing, the notification application, the reporting application, and the re-verification application can be composed of code to drive the software or hardware of the electronic device to achieve the purpose of the application.
此外，因應不同的使用場域，前述的身份、識別碼、關聯識別碼、檢測結果、第一狀態、第二狀態、無法判定狀態等可以被儲存在本地伺服器及/或雲端伺服器。又，識別碼經綁定形成關聯識別碼之後，藉由儲存在本地伺服器及/或雲端伺服器，可以驗證識別碼在本地伺服器與雲端伺服器禁止再次被綁定。 In addition, in response to different fields of use, the aforementioned identity, identification code, associated identification code, detection result, first state, second state, undeterminable state, etc. can be stored in a local server and/or a cloud server. Furthermore, after the identification code is bound to form an associated identification code, by storing it in the local server and/or the cloud server, it can be verified that the identification code is prohibited from being bound again on the local server and the cloud server.
請參考圖5，係本創作第三實施例之生物感染檢測與人員管制方法之流程圖。在圖5中，生物感染檢測與人員管制方法除包含步驟S11至S16之外，更包含步驟S51。 Please refer to FIG. 5, which is a flowchart of the biological infection detection and personnel control method according to the third embodiment of the present creation. In FIG. 5, the biological infection detection and personnel control method not only includes steps S11 to S16, but also includes step S51.
步驟S11至S16的描述同前所述，於此不贅述。 The description of steps S11 to S16 is the same as that described above, and will not be repeated here.
步驟S51，係根據第一狀態、第二狀態或無法判定狀態選擇性對被篩檢者實施一行動管制。本步驟可以依照第一狀態、第二狀態或無法判定狀態，對該等狀態對應的被篩檢者進行管理、管制、控管等。 Step S51 is to selectively implement an action control on the screened person according to the first state, the second state or the undecidable state. In this step, the screened persons corresponding to these states can be managed, controlled, controlled, etc. according to the first state, the second state, or the undecidable state.
舉例而言，在虛擬地圖劃定被篩檢者的活動範圍，以在虛擬地圖所對應的實際地理位置建立虛擬電子圍欄。在建立虛擬電子圍欄之後，取得被篩檢者在實際地理位置的座標，以及比對座標與虛擬地圖，以判斷被篩檢者是否位於虛擬電子圍欄，進而達到將特別具有例如陽性檢測結果或是無法判定檢測結果的被篩檢者限制或隔離在虛擬電子圍欄內，以避免感染其他人。 For example, the activity range of the screened person is delineated on the virtual map to establish a virtual electronic fence at the actual geographic location corresponding to the virtual map. After the virtual electronic fence is established, the coordinates of the screened person’s actual geographic location are obtained, and the coordinates are compared with the virtual map to determine whether the screened person is in the virtual electronic fence. Those screened who cannot determine the test result are restricted or isolated in a virtual electronic fence to avoid infecting other people.
於另一實施例，被篩檢者也可以自行確認自身的座標與虛擬電子圍欄的關係，也就是被篩檢者可以透過顯示自身的座標與虛擬電子圍欄而確定自身的活動範圍。另外，還可以藉由連續地紀錄被篩檢者的座標，以建立被篩檢 者的移動軌跡，以提供調查被篩檢者行走過的路徑，進而可以了解被篩檢者可能觸及過的人、事、地與物。 In another embodiment, the screened person can also confirm the relationship between his own coordinates and the virtual electronic fence, that is, the screened person can determine his own range of activities by displaying his own coordinates and the virtual electronic fence. In addition, it is also possible to continuously record the coordinates of the screened person to establish the screened The trajectory of the person’s movement to provide an investigation of the path that the person being screened has walked, so as to understand the people, things, places, and objects that the person being screened may have touched.
在另一個情境中，針對一般民眾或是被篩檢者屬於陰性的人而言，若能知道屬於陽性或無法判斷的被篩檢者的位置，則可以避免前往或是遠離存在陽性或狀態不明的被篩檢者所處的位置或所觸及的人、事、地與物，具體的實施的方式可舉例如下： In another situation, for the general public or those who are screened as negative, if you can know the location of the screened person who is positive or cannot be judged, you can avoid or stay away from the presence of positive or unknown status The location of the screened person or the people, things, places and things touched, the specific implementation methods can be exemplified as follows:
方式一：若所有經過篩檢的被篩檢者都提供自身的座標，使得該等坐標可以伴隨著檢測結果，而能夠確保彼此的安全距離。具體的作法舉例為取得複數被篩檢者之每一者的座標。藉由演算屬於第一狀態或無法判定狀態之該等被篩檢者的第一座標與屬於該第二狀態之該等被篩檢者的第二座標，以計算出距離；以及判斷距離不大於預定安全距離，例如預定安全距離為數公尺，且進一步執行警示應用程序，以將通知屬於第一狀態或無法判定狀態之該等被篩檢者與屬於該第二狀態之該等被篩檢者保持在預定安全距離或大於預定安全距離。其中，執行警示應用程序，可以發出警報通知第二狀態之該等被篩檢者，其接近第一狀態或無法判定狀態之該等被篩檢者的距離已經鄰近或是在預定安全距離，應該遠離；或是，於另一實施例中，在地圖上可以判斷哪些位置有第一狀態或無法判定狀態之該等被篩檢者，具有高風險性，提醒第二狀態之該等被篩檢者不要前往地圖上標示有高風險性的位置。 Method 1: If all screened persons who have passed the screening provide their own coordinates, so that these coordinates can be accompanied by the detection results, and a safe distance between each other can be ensured. An example of a specific practice is to obtain the coordinates of each of the plural screened persons. Calculate the distance by calculating the first coordinates of the screened persons belonging to the first state or the undeterminable state and the second coordinates of the screened persons belonging to the second state; and determining that the distance is not greater than The predetermined safety distance, for example, the predetermined safety distance is a few meters, and the warning application program is further executed to notify the screened persons belonging to the first state or the undeterminable state and the screened persons belonging to the second state Keep at a predetermined safe distance or greater than the predetermined safe distance. Among them, the execution of the warning application program can issue an alarm to notify the screened persons in the second state that the distance between the screened persons in the first state or the undeterminable state is close or at a predetermined safe distance. Far away; or, in another embodiment, it is possible to determine which locations on the map have the first state or the undeterminable state of the screened persons, which has a high risk, and remind the second state of the screened persons Do not go to locations marked with high risk on the map.
方式二：在該虛擬地圖標記屬於第一狀態或無法判定狀態之被篩檢者的座標，以選擇性推播與顯示於任何人或指定人。 Method 2: Mark the coordinates of the screened persons who belong to the first state or the undeterminable state on the virtual map, and selectively push and display them to any person or designated person.
在對被篩檢者實施一行動管制的過程中，若被篩檢者需要取得幫助，可以藉由執行救助應用程序，以將被篩檢者持有電子裝置的位置資訊 發送至預設的接收者，例如接收者可為醫院、消防局、疾病管制署、警察局等。舉例而言，救助應用程序可以在被篩檢者執行之後，啟動撥接功能，自動發出位置資訊，供接收者根據位置資訊，找尋被篩檢者。於另一實施例中，可以讓被篩檢者留在原地，讓醫院利用隔離艙或發燒帳的隔離方式送醫院檢查。 In the process of implementing a movement control on the screened person, if the screened person needs help, the rescue application can be executed to obtain the location information of the screened person’s electronic device Send to a preset recipient, for example, the recipient can be a hospital, fire department, disease control department, police station, etc. For example, the rescue application can activate the dial-up function after the screened person is executed, and automatically send location information for the recipient to find the screened person based on the location information. In another embodiment, the screened person can be left in place, and the hospital can be sent to the hospital for examination using the isolation cabin or fever account.
參考圖6，係本創作第四實施例之生物感染應變系統之方塊圖。在圖6中，提供生物感染應變系統10能夠提供具有一識別碼22與一檢測區24的一篩檢套件2檢測一被篩檢者4是否受到感染與針對被篩檢者4選擇性實施一行動管制。其中，被篩檢者4之生物樣本42設置於檢測區24，且生物樣本42係直接採檢被篩檢者4的一組織或一體液所獲得或生物樣本42係在採檢被篩檢者4的組織或體液後進一步混合一試劑所獲得，例如生物樣本42可以是呼吸道粘膜、唾液、細包膜、呼出氣體、飛沫、組織細胞、DNA等。舉例而言，以新冠病毒(COVID-19)的檢測方式為例，其檢測的方法包含但不限於核酸檢測、血清抗體快篩、抗原快篩等方式。
Refer to Figure 6, which is a block diagram of the biological infection response system of the fourth embodiment of the present creation. In FIG. 6, providing a biological
生物感染應變系統10包含一輸入元件12與一處理元件14。
The biological
輸入元件12設置於篩檢套件2以取得檢測區24顯示檢測結果DR。其中，檢測結果DR為一影像型態與一文字型態之至少一者。舉例而言，輸入元件12為影像擷取元件，藉由影像擷取元件掃描識別碼22以提供處理元件14綁定識別碼22與被篩檢者的身份ID。
The
處理元件14連接輸入元件12，且處理元件14執行一生物感染檢測程序BIDAPP綁定識別碼22與被篩檢者4的身份ID以關聯篩檢套件2與身份ID。生物感染檢測程序BIDAPP綁定識別碼22與身份ID的方式可以參照前述時施力的說明。
The
又，處理元件14執行生物感染檢測程序BIDAPP還可以進一步判斷生物樣本42屬於一第一狀態FS、一第二狀態SS或一無法判定狀態LOJS。其中，關於第一狀態FS、一第二狀態SS或一無法判定狀態LOJS可以參照前述實施例中的說明。
In addition, the
參考圖7，係本創作第五實施例之生物感染應變系統之方塊圖。在圖7中，提供生物感染應變系統10’除包含第四實施例的輸入元件12與處理元件14的硬體元件且處理元件14執行生物感染檢測程序BIDAPP之外，處理元件14更執行生物感染人員管制應用程序BIPCAPP，以根據第一狀態FS、第二狀態SS或該無法判定狀態LOJS選擇性對被篩檢者4實施行動管制。舉例而言，生物感染人員管制應用程序BIPCAPP可以在虛擬地圖(例如Google提供的圖資等)劃定被篩檢者的活動範圍，而在虛擬地圖對應的實際地理位置建立虛擬電子圍欄，以將被篩檢者4管制於虛擬電子圍欄。值得注意的是，於此所稱的虛擬電子圍欄並非實際在現實的地理位置上產生一片牆面，而是用來說明在虛擬地圖規劃一個活動範圍之後，可以理解到，這個活動範圍所圍繞的邊界，是由許多點座標所構成，又連續的點座標形成線段，當生物感染人員管制應用程序BIPCAPP演算被篩檢者4的座標與邊線的每一座標或線段時，生物感染人員管制應用程序BIPCAPP可以判斷被篩檢者4的座標鄰近、在邊界上的任一座標或是越過邊界座標，由於在虛擬地圖對應真實地理位置，因此，在虛擬地圖的判斷也可以轉換成真實地理位置的判斷。因此，在真實地理位置對於被篩檢者4是具有看不到的虛擬電子圍欄。
Refer to Figure 7, which is a block diagram of the biological infection response system of the fifth embodiment of the present creation. In FIG. 7, a biological infection response system 10' is provided. In addition to the hardware components including the
於另一實施例中，生物感染人員管制應用程序BIPCAPP更可以在被篩檢者4為複數者時，演算屬於第一狀態FS或無法判定狀態LOJS之該
等被篩檢者4的第一座標與屬於第二狀態SS之該等被篩檢者4的第二座標，以計算出第一座標與第二座標之間的距離，且在判斷距離不大於預定安全距離時，透過處理元件14通知屬於第一狀態FS或無法判定狀態LOJS之該等被篩檢者4與屬於第二狀態SS之該等被篩檢者4保持在預定安全距離或大於預定安全距離。
In another embodiment, BIPCAPP, a biologically infected person control application, can also calculate whether the screened
於另一實施例中，生物感染人員管制應用程序BIPCAPP可以演算屬於第一狀態FS或無法判定狀態LOJS之被篩檢者的第一座標並標記於虛擬地圖，以選擇性向任何人或指定人推播與顯示具有第一狀態FS或無法判定狀態LOJS之被篩檢者的第一座標。藉由向任何人或指定人推播與顯示第一座標，可以避免任何人或指定人向具有第一狀態FS或無法判定狀態LOJS之被篩檢者4移動，減低被具有第一狀態FS或無法判定狀態LOJS之被篩檢者4感染的風險。
In another embodiment, the biologically infected personnel control application BIPCAPP can calculate the first coordinates of the screened persons belonging to the first state FS or the undeterminable state LOJS and mark them on the virtual map to selectively push to any person or designated person Broadcast and display the first coordinates of the screened person with the first state FS or the undeterminable state LOJS. By pushing and displaying the first coordinates to any person or designated person, it is possible to prevent anyone or designated person from moving to the screened
以上實施方式本質上僅為輔助說明，且並不欲用以限制申請標的之實施例或該等實施例的應用或用途。此外，儘管已於前述實施方式中提出至少一例示性實施例，但應瞭解本創作仍可存在大量的變化。同樣應瞭解的是，本文所述之實施例並不欲用以透過任何方式限制所請求之申請標的之範圍、用途或組態。相反的，前述實施方式將可提供本領域具有通常知識者一種簡便的指引以實施所述之一或多種實施例。再者，可對元件之功能與排列進行各種變化而不脫離申請專利範圍所界定的範疇，且申請專利範圍包含已知的均等物及在本專利申請案提出申請時的所有可預見均等物。 The above implementations are essentially only supplementary explanations, and are not intended to limit the embodiments of the application subject or the applications or uses of the embodiments. In addition, although at least one exemplary embodiment has been proposed in the foregoing implementation manners, it should be understood that there are still a large number of changes in this creation. It should also be understood that the embodiments described herein are not intended to limit the scope, use, or configuration of the requested subject matter in any way. On the contrary, the foregoing embodiments will provide a convenient guide for those skilled in the art to implement one or more embodiments. Furthermore, various changes can be made to the function and arrangement of the components without departing from the scope defined by the scope of the patent application, and the scope of the patent application includes known equivalents and all foreseeable equivalents at the time of application of this patent application.
2:篩檢套件 2: Screening kit
22:識別碼 22: identification code
24:檢測區 24: detection area
4:被篩檢者 4: Screened person
42:生物樣本 42: Biological sample
10:生物感染應變系統 10: Biological infection response system
12:輸入元件 12: Input components
14:處理元件 14: processing components
DR:檢測結果 DR: test result
BIDAPP:生物感染檢測程序 BIDAPP: Biological infection detection program
ID:身份 ID: Identity
FS:第一狀態 FS: first state
SS:第二狀態 SS: second state
LOJS:無法判定狀態 LOJS: Unable to determine status
Claims (18)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW110200691U TWM616223U (en) | 2021-01-20 | 2021-01-20 | Biological infection response system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW110200691U TWM616223U (en) | 2021-01-20 | 2021-01-20 | Biological infection response system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWM616223U true TWM616223U (en) | 2021-09-01 |
Family
ID=78778379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110200691U TWM616223U (en) | 2021-01-20 | 2021-01-20 | Biological infection response system |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWM616223U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI774202B (en) * | 2021-01-20 | 2022-08-11 | 張文瀚 | Biological infection detection method, biological infection detection and personnel control method and biological infection response system |
-
2021
- 2021-01-20 TW TW110200691U patent/TWM616223U/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI774202B (en) * | 2021-01-20 | 2022-08-11 | 張文瀚 | Biological infection detection method, biological infection detection and personnel control method and biological infection response system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210358068A1 (en) | Method for issuing a verified health pass, use thereof for entering a venue and contact tracing method | |
| CN111403006B (en) | Microorganism detection system and device | |
| JP6667052B1 (en) | Device and method for authenticating a sample and use thereof | |
| EP4181049A1 (en) | Information processing method | |
| CN107680682A (en) | Chronic Non-Communicable Diseases cohort study crowd's follow-up method based on wechat platform | |
| JP2020080083A (en) | Pathogen information management system, pathogen information management method, and information terminal | |
| TWM616223U (en) | Biological infection response system | |
| Aydemir et al. | A system design with deep learning and IoT to ensure education continuity for post-COVID | |
| US20220044827A1 (en) | Biological infection detection method, biological infection detection and personnel control method and biological infection response system | |
| TWI774202B (en) | Biological infection detection method, biological infection detection and personnel control method and biological infection response system | |
| AU2020102382A4 (en) | An artificial intelligence based system for covid prevention | |
| Radhi | Use QR Code and IoT Mobile Devices to Prevent the Spread of an Epidemic (COVID-19). | |
| JP2022017073A (en) | Infectious disease countermeasure system | |
| Khan et al. | Harnessing intelligent technologies to curb COVID-19 pandemic: taxonomy and open challenges | |
| NL2027869B1 (en) | Apparatus and method for producing immunity certificates | |
| Dawood et al. | COVID-19 artificial intelligence based surveillance applications in the kingdom of Saudi Arabia | |
| JP2011002407A (en) | Alcohol testing device | |
| CN116830206A (en) | Contactless infectious disease screening | |
| CN208892555U (en) | Measurement of bldy temperature system | |
| Jack et al. | Development of a Remote Visitor’s Health Assessment and Documentary Model for Coronavirus Applications | |
| US20240153617A1 (en) | Information processing method and information processing system | |
| WO2022113148A1 (en) | Server device, system, control method of server device, and storage medium | |
| AU2021103658A4 (en) | Iot based smart pandemic detection device and method for pandemic preventive measures | |
| KR102485383B1 (en) | Controlling System Based on Point-Of-Care Test, Server For The Same And Method of Point-Of-Care Test Using The Same | |
| Muleta et al. | Validity of A Mobile Phone-based Application Tool for COVID-19 Self Screening |